US estimates of hospitalized pediatric patients with ulcerative colitis: Implications for multicenter clinical studies

Inflammatory Bowel Diseases

Volumn 14, Issue 9, 2008, Pages 1253-1258

  Guthery, Stephen L ^a   Dong, Lydia ^a   Dean, J Michael ^a   Holubkov, Richard ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Healthcare cost; Kids inpatient database; Pediatrics; Ulcerative colitis; Utilization project

Indexed keywords

CYCLOSPORIN; GLUCOCORTICOID; INFLIXIMAB; PLACEBO; TACROLIMUS; VISILIZUMAB;

ADOLESCENT; ARTICLE; CHILD; CHILD CARE; CHILD HOSPITALIZATION; CLINICAL RESEARCH; CLINICAL TRIAL; COLON RESECTION; CONTROLLED CLINICAL TRIAL; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LENGTH OF STAY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT CARE; PILOT STUDY; PRIORITY JOURNAL; SAMPLE SIZE; SIMULATION; ULCERATIVE COLITIS; UNITED STATES;

ADOLESCENT; COLITIS, ULCERATIVE; FEMALE; HEALTH SURVEYS; HOSPITALIZATION; HOSPITALS, PEDIATRIC; HUMANS; MALE; UNITED STATES;

EID: 54349112383     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20521     Document Type: Article

References (40)

1. Swerdlow AJ, Higgins CD, Hunt BJ, et al. Risk of lymphoid neoplasia after cardiothoracic transplantation. A cohort study of the relation to Epstein-Barr virus. Transplantation. 2000;69:897-904.
2. Guthery SL, Heubi JE, Bucuvalas JC, et al. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment. Transplantation. 2003;75:987-993.
3. Kugathasan S, Dubinsky MC, Keljo D, et al. Severe colitis in children. J Pediatr Gastroenterol Nutr. 2005;41:375-385.
4. Bousvaros A, Sylvester F, Kugathasan S, et al. Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:885-913.
5. Buller H, Chin S, Kirschner B, et al. Inflammatory bowel disease in children and adolescents: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2002;35(suppl 2):S151-158.
6. Elson CO, Sartor RB, Targan SR, et al. Challenges in IBD research: updating the scientific agendas. Inflamm Bowel Dis. 2003; 9:137-153.
7. Gurney J, Smith M, Bunin G. ICNS and miscellaneous intracranial and intraspinal neoplasms. In: Ries L, Smith M, Gurney J, et al, eds. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute; 1999.
8. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003;143:525-531.
9. Smith M, Ries L, Gurney J, et al. Leukemia. In: Ries L, Smith M, Gurney J, et al, eds. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute; 1999.
10. Healthcare Cost and Utilization Project. Introduction to the HCUP Kids' Inpatient Database (KID), 2003. 2005:1-34.
11. Ho GT, Mowat C, Goddard CJ, et al. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther. 2004;19:1079-1087.
12. Lindgren SC, Flood LM, Kilander AF, et al. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol. 1998;10:831-835.
13. Seo M, Okada M, Yao T, et al. Evaluation of the clinical course of acute attacks in patients with ulcerative colitis through the use of an activity index. J Gastroenterol. 2002;37:29-34.
14. Travis SP, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut. 1996;38:905-910.
15. Turner D, Walsh CM, Benchimol EI, et al. Severe paediatric ulcerative colitis: incidence, outcomes, and optimal timing for second line therapy. Gut. 2008;57:331-338.
16. Plevy S, Salzberg B, Van Assche G, et al. A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology. 2007;133:1414-1422.
17. Sands BE, Tremaine WJ, Sandborn WJ, et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis. 2001;7:83-88.
18. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994;330: 1841-1845.
19. Mahadevan U, Tremaine WJ, Johnson T, et al. Intravenous azathioprine in severe ulcerative colitis: a pilot study. Am J Gastroenterol. 2000;95: 3463-3468.
20. Woodruff RS. A simple method for approximating the variance of a complicated estimate. J Am Stat Assoc. 1971;66:411-414.
21. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
22. Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/ Deyo methods of comorbidity measurement in administrative data. Med Care. 2004;42:355-360.
23. Healthcare Cost and Utilization Project, Introduction to the HCUP Kids' Inpatient Database (KID), 2000. 2005:1-18.
24. Bresci G, Parisi G, Mazzoni A, et al. Treatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot study. Dig Liver Dis. 2007;39:430-434.
25. Sands BE, Sandborn WJ, Wolf DC, et al. Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease. J Clin Gastroenterol. 2006;40:482-489.
26. Ochsenkuhn T, Sackmann M, Goke B. Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study. Eur J Gastroenterol Hepatol. 2004;16:1167-1171.
27. Hanai H, Watanabe F, Takeuchi K, et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol. 2003;1:28-35.
28. Ang YS, Mahmud N, White B, et al. Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease. Aliment Pharmacol Ther. 2000;14:1015-1022.
29. Lichtiger S, Present DH. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet. 1990;336:16-19.
30. Kaser A, Mairinger T, Vogel W, et al. Infliximab in severe steroid-refractory ulcerative colitis: a pilot study. Wien Klin Wochenschr. 2001; 113:930-933.
31. Kohn A, Prantera C, Pera A, et al. Infliximab in the treatment of severe ulcerative colitis: a follow-up study. Eur Rev Med Pharmacol Sci. 2004;8:235-237.
32. Bousvaros A, Kirschner BS, Werlin SL, et al. Oral tacrolimus treatment of severe colitis in children. J Pediatr. 2000;137:794-799.
33. Turner D, Otley A, Mack D, et al. Development, validation, and evaluation of a Pediatric Ulcerative Colitis Activity Index: a prospective multicenter study. Gastroenterology. 2007;133:423-432.
34. Jarnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology. 2005;128:1805-1811.
35. Ogata H, Matsui T, Nakamura M, et al. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut. 2006;55:1255-1262.
36. Nguyen GC, Laveist TA, Gearhart S, et al. Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol. 2006;4:1507-1513.
37. Bleyer WA. The U.S. pediatric cancer clinical trials programmes: international implications and the way forward. Eur J Cancer. 1997;33: 1439-1447.
38. The Pediatric Emergency Care Applied Research Network (PECARN): rationale, development, and first steps. Acad Emerg Med. 2003;10:661-668.
39. Corneli HM, Zorc JJ, Majahan P, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med. 2007;357:331-339.
40. Willson DF, Dean JM, Newth C, et al. Collaborative Pediatric Critical Care Research Network (CPCCRN). Pediatr Crit Care Med. 2006;7: 301-307.